313 related articles for article (PubMed ID: 35054976)
21. VGLUTs: 'exciting' times for glutamatergic research?
Takamori S
Neurosci Res; 2006 Aug; 55(4):343-51. PubMed ID: 16765470
[TBL] [Abstract][Full Text] [Related]
22. Paradoxical network excitation by glutamate release from VGluT3
Pelkey KA; Calvigioni D; Fang C; Vargish G; Ekins T; Auville K; Wester JC; Lai M; Mackenzie-Gray Scott C; Yuan X; Hunt S; Abebe D; Xu Q; Dimidschstein J; Fishell G; Chittajallu R; McBain CJ
Elife; 2020 Feb; 9():. PubMed ID: 32053107
[TBL] [Abstract][Full Text] [Related]
23. Cellular localization of three vesicular glutamate transporter mRNAs and proteins in rat spinal cord and dorsal root ganglia.
Oliveira AL; Hydling F; Olsson E; Shi T; Edwards RH; Fujiyama F; Kaneko T; Hökfelt T; Cullheim S; Meister B
Synapse; 2003 Nov; 50(2):117-29. PubMed ID: 12923814
[TBL] [Abstract][Full Text] [Related]
24. VGLUT3 neurons in median raphe control the efficacy of spatial memory retrieval via ETV4 regulation of VGLUT3 transcription.
He A; Zhang C; Ke X; Yi Y; Yu Q; Zhang T; Yu H; Du H; Li H; Tian Q; Zhu LQ; Lu Y
Sci China Life Sci; 2022 Aug; 65(8):1590-1607. PubMed ID: 35089530
[TBL] [Abstract][Full Text] [Related]
25. Vesicular glutamate transporter 3 immunoreactivity is present in cholinergic basal forebrain neurons projecting to the basolateral amygdala in rat.
Nickerson Poulin A; Guerci A; El Mestikawy S; Semba K
J Comp Neurol; 2006 Oct; 498(5):690-711. PubMed ID: 16917846
[TBL] [Abstract][Full Text] [Related]
26. Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus.
Gonçalves FQ; Pires J; Pliassova A; Beleza R; Lemos C; Marques JM; Rodrigues RJ; Canas PM; Köfalvi A; Cunha RA; Rial D
Eur J Neurosci; 2015 Apr; 41(7):878-88. PubMed ID: 25704806
[TBL] [Abstract][Full Text] [Related]
27. Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior.
Ibrahim KS; Abd-Elrahman KS; El Mestikawy S; Ferguson SSG
Mol Pharmacol; 2020 Oct; 98(4):314-327. PubMed ID: 32873747
[TBL] [Abstract][Full Text] [Related]
28. Leveraging VGLUT3 Functions to Untangle Brain Dysfunctions.
Favier M; Pietrancosta N; El Mestikawy S; Gangarossa G
Trends Pharmacol Sci; 2021 Jun; 42(6):475-490. PubMed ID: 33775453
[TBL] [Abstract][Full Text] [Related]
29. VGLUT3-immunoreactive afferents of the lateral septum: ultrastructural evidence for a modulatory role of glutamate.
Riedel A; Stöber F; Richter K; Fischer KD; Miettinen R; Budinger E
Brain Struct Funct; 2013 Jan; 218(1):295-301. PubMed ID: 22374223
[TBL] [Abstract][Full Text] [Related]
30. The expression of vesicular glutamate transporter 3 and vesicular monoamine transporter 2 induced by brain-derived neurotrophic factor in dorsal root ganglion neurons in vitro.
Liu D; Bi Y; Liu Z; Liu H; Li Z
Brain Res Bull; 2014 Jan; 100():93-106. PubMed ID: 24316448
[TBL] [Abstract][Full Text] [Related]
31. Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters.
Boulland JL; Qureshi T; Seal RP; Rafiki A; Gundersen V; Bergersen LH; Fremeau RT; Edwards RH; Storm-Mathisen J; Chaudhry FA
J Comp Neurol; 2004 Dec; 480(3):264-80. PubMed ID: 15515175
[TBL] [Abstract][Full Text] [Related]
32. Developmentally regulated expression of VGLUT3 during early post-natal life.
Gras C; Vinatier J; Amilhon B; Guerci A; Christov C; Ravassard P; Giros B; El Mestikawy S
Neuropharmacology; 2005 Nov; 49(6):901-11. PubMed ID: 16182324
[TBL] [Abstract][Full Text] [Related]
33. The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.
Sakae DY; Marti F; Lecca S; Vorspan F; Martín-García E; Morel LJ; Henrion A; Gutiérrez-Cuesta J; Besnard A; Heck N; Herzog E; Bolte S; Prado VF; Prado MA; Bellivier F; Eap CB; Crettol S; Vanhoutte P; Caboche J; Gratton A; Moquin L; Giros B; Maldonado R; Daumas S; Mameli M; Jamain S; El Mestikawy S
Mol Psychiatry; 2015 Nov; 20(11):1448-59. PubMed ID: 26239290
[TBL] [Abstract][Full Text] [Related]
34. VGLUT3 Ablation Differentially Modulates Glutamate Receptor Densities in Mouse Brain.
Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG
eNeuro; 2022; 9(3):. PubMed ID: 35443989
[TBL] [Abstract][Full Text] [Related]
35. Role of the vesicular transporter VGLUT3 in retrograde release of glutamate by cerebellar Purkinje cells.
Crépel F; Galante M; Habbas S; McLean H; Daniel H
J Neurophysiol; 2011 Mar; 105(3):1023-32. PubMed ID: 21177991
[TBL] [Abstract][Full Text] [Related]
36. Molecular, Structural, Functional, and Pharmacological Sites for Vesicular Glutamate Transporter Regulation.
Pietrancosta N; Djibo M; Daumas S; El Mestikawy S; Erickson JD
Mol Neurobiol; 2020 Jul; 57(7):3118-3142. PubMed ID: 32474835
[TBL] [Abstract][Full Text] [Related]
37. Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input-specific retrograde signalling by cholinergic neurons.
Harkany T; Härtig W; Berghuis P; Dobszay MB; Zilberter Y; Edwards RH; Mackie K; Ernfors P
Eur J Neurosci; 2003 Oct; 18(7):1979-92. PubMed ID: 14622230
[TBL] [Abstract][Full Text] [Related]
38. Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice.
Ruel J; Emery S; Nouvian R; Bersot T; Amilhon B; Van Rybroek JM; Rebillard G; Lenoir M; Eybalin M; Delprat B; Sivakumaran TA; Giros B; El Mestikawy S; Moser T; Smith RJ; Lesperance MM; Puel JL
Am J Hum Genet; 2008 Aug; 83(2):278-92. PubMed ID: 18674745
[TBL] [Abstract][Full Text] [Related]
39. Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system.
Liguz-Lecznar M; Skangiel-Kramska J
Acta Neurobiol Exp (Wars); 2007; 67(3):207-18. PubMed ID: 17957901
[TBL] [Abstract][Full Text] [Related]
40. LSP5-2157 a new inhibitor of vesicular glutamate transporters.
Poirel O; Mamer LE; Herman MA; Arnulf-Kempcke M; Kervern M; Potier B; Miot S; Wang J; Favre-Besse FC; Brabet I; Laras Y; Bertrand HO; Acher F; Pin JP; Puel JL; Giros B; Epelbaum J; Rosenmund C; Dutar P; Daumas S; El Mestikawy S; Pietrancosta N
Neuropharmacology; 2020 Mar; 164():107902. PubMed ID: 31811873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
